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A qualitative study of GP, nurse and practice manager views
on using targeted case-ﬁnding to identify patients with COPD
in primary care
Rachael H. Summers1, Taniya Sharmeen2, Kate Lippiett1, Kate Gillett3,4, Carla Astles3,4, Linh Vu5, Mark Stafford-Watson3,
Anne Bruton1,3,6, Mike Thomas3,7 and Tom Wilkinson3,6,8
‘Finding the missing millions’ with chronic obstructive pulmonary disease became part of the Department of Health strategy for
England in 2010. Targeted case-ﬁnding within primary care is one potential pro-active strategy, but currently little is known about
the views of healthcare professionals on this approach. In this study, 36 healthcare professionals (12 GPs, 14 nurses, and 10 practice
managers) from 34 UK practices participated in semi-structured telephone interviews about targeted case-ﬁnding. Interviews
followed an interview guide, were audio-recorded, transcribed verbatim, coded and analysed using ‘Framework Approach’. Most of
those interviewed practiced opportunistic case-ﬁnding. The main perceived barriers to wider case-ﬁnding programmes were the
resource implications associated with running such programmes and identifying more chronic obstructive pulmonary disease
patients. Financial incentives, support from specialist clinicians, and comprehensive guidance were viewed as facilitators. While
targeted case-ﬁnding is conceptually accepted by primary care staff, scepticism surrounding (1) the value of identifying those with
mild disease and (2) the availability of effective targeted case-ﬁnding methods, may lead some to favour an opportunistic approach.
Key concerns were a lack of unequivocal evidence for the relative beneﬁts vs. disadvantages of diagnosing patients earlier, and
resource constraints in an already over-burdened system. Barriers to practical implementation of case-ﬁnding studies may be
addressed with ﬁnancial, human and educational resources, such as additional staff to undertake searches and perform spirometry
tests, and practical and educational support from specialist teams.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) costs the United
Kingdom (UK) economy £2.7 billion per year in lost working days
and costs the NHS £800 million per year.1, 2 The greatest cost is
associated with hospital admissions for those with severe/very
severe COPD.1 Early diagnosis of COPD has the potential to reduce
these costs, because although COPD cannot be cured, it is
treatable once a diagnosis has been made.3 Early diagnosis is,
therefore, a key tenet of the UK’s national strategy for managing
COPD.4
In the UK, it is estimated that 2 million people with COPD
remain undiagnosed,5 with a diagnosis often not being made until
disease is relatively advanced.6 There are several reasons for this
delay in diagnosis. As the disease usually has an insidious onset,
patients may initially attribute symptoms to those expected of
normal ageing, or from smoking, and so avoid seeking medical
advice.7 A general lack of public awareness about COPD may also
contribute to late presentation.8 Evidence also suggests that
opportunities for diagnosis in primary care may be missed, with
many patients presenting with COPD-related symptoms (such as
cough and breathlessness) being misdiagnosed as simple
respiratory tract infections, rather than acute exacerbations of
COPD. Jones et al.6 retrospective analysis of 38,859 patient cases
revealed that in the 5 years immediately before diagnosis, there
were missed diagnostic opportunities in 85% of patients.
Two related approaches for diagnosing COPD available are
population-based screening (testing all at high risk including
asymptomatic patients), and targeted case-ﬁnding (testing those
with risk factors, symptoms or health resource utilisation patterns
suggestive of COPD). Screening asymptomatic at-risk populations
is not currently supported by the evidence,9, 10 but identifying
COPD in symptomatic patients is advocated3, 10 and supported by
research.11 Case-ﬁnding for COPD may be either targeted (where
symptomatic patients with known risk factors are systematically
identiﬁed) or opportunistic (where symptomatic patients with
known risk factors are identiﬁed when they attend for routine
healthcare consultations).12 Haroon et al.13 identiﬁed a number of
approaches for COPD case ﬁnding in primary care. Approaches
included targeted and opportunistic case-ﬁnding. Screening
questionnaires, handheld metres to identify airﬂow obstruction
and direct invitations for diagnostic spirometry were used either in
as combined or as standalone approaches. However relatively
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little is known about the views on case-ﬁnding of those working in
primary care, who have to administer the case-ﬁnding programme
and deal with the consequences of additional newly diagnosed
patients. Historically, clinicians have been reported to hold
nihilistic attitudes towards the diagnosis of COPD,14 so under-
standing their views and identifying facilitators and barriers to
implementation is likely to be important to conducting successful
case-ﬁnding initiatives. Case-ﬁnding initiatives have implications
for the entire primary healthcare team, including non-clinical staff,
and understanding their concerns and motivations is important.
While there have been clinician commentaries on the value of
case-ﬁnding15, 16 and the general importance of COPD in primary
care has been explored,17 only Haroon et al.18 qualitative study
has speciﬁcally explored primary care staff views on case-ﬁnding.
While this study makes an important contribution, ﬁnding interest
in case-ﬁnding despite concerns over ﬁnancing and capacity, it
was restricted to practices in the West Midlands, involved only
three practice managers, and all practices were already participat-
ing in a trial of case-ﬁnding. This may have affected the views
expressed, as those included probably already had an interest in
case-ﬁnding. Further research into general practice staff’s views
involving a sample independent of a case-ﬁnding trial is needed
to increase our understanding of how case-ﬁnding is viewed in
the wider primary care staff population. This study aimed to
explore the views of GPs, nurses and practice managers on
targeted case-ﬁnding for COPD within general practices in the
South of England.
RESULTS
A total of 42 people from 37 practices responded to the initial
contact (15 GPs, 17 Nurses, and 10 Practice Managers). Of those
initially responding, 36 staff (12 GPs, 14 Nurses, and 10 Practice
Managers) (Table 1) from across 34 GP practices (Table 2) were
interviewed. Of those not interviewed: (i) four did not respond to
follow-up contact, (ii) one withdrew before the interview for
personal reasons, and (iii) one nurse was not interviewed as s/he
was not demographically dissimilar to other participants in the
nurse sample, and data saturation was judged to have been
reached. Data were organised into two themes:
Positions on diagnosing COPD: contains views on COPD
diagnosis in terms of its importance both generally and at a
practice level, and perceived advantages and drawbacks.
Views on approaches to COPD case-ﬁnding: summarises data
relating to views regarding the value and desirability of different
case-ﬁnding strategies, the relative pros and cons of targeted
case-ﬁnding, and interviewees’ self-reported willingness to parti-
cipate in externally run targeted case-ﬁnding initiatives.
Positions on diagnosing COPD
All the participants considered diagnosing COPD to be important.
Advantages ascribed to diagnosing COPD included: giving
patients the knowledge, and possibly motivation, to make positive
lifestyle changes; ensuring medical management was optimal,
thereby enhancing patient quality of life; and saving NHS
resources through reduced admissions for exacerbations and
other problems associated with COPD.
I think that’s an important thing to do and obviously by
stopping the decline in lung function, we can keep patients
better, more well for longer, and also reduce the impact the
disease has not only on themselves but on the NHS in terms of
exacerbations, prescriptions involving expensive medication.
[GP 10102, Male]
However, clinician views differed regarding the ‘best’ time to
diagnose COPD (while practice managers did not discuss this). A
majority of GPs and nurses (23/26) argued that diagnosing COPD
as early as possible was key, including those with mild COPD.
if you found them around the 80 per cent or just below the 80
per cent when they had much milder damage and they
stopped smoking, they exercised, they’d got their ﬂu and
pneumonia jabs, looked after themselves, it would make such a
lot of difference in the long run [Practice Nurse 19215, Female]
Three GP interviewees were unconvinced as to the value of
diagnosing mild COPD and/or those who were asymptomatic.
While these GPs considered diagnosing people with mild COPD to
be beneﬁcial if it resulted in smoking cessation, no other beneﬁts
to diagnosing COPD in the mild stage were perceived. Further-
more, they viewed the consequence of having to see those withTable 1. Participant characteristics
Characteristics General
Practitioner
Nurse Practice
manager
Staff interviewed (n=
36)
12 14 10
Age range in years
(Mean)
32–60(45) 38–59(49) 34–54(42)
Sex
Female 5 14 9
Male 7 0 1
Length of practice experience
<5 years 2 1 5
6–10 years 4 6 1
>10 years 6 7 4
COPD lead 5 9 N/A
Nurse role
Practice Nurse N/A 13 N/A
Nurse Practitioner 1
Partnership in the
practice
11 N/A N/A
Table 2. Practice characteristics
Characteristic Number
Total number of practices 34
Practice list sizes
Range 3670–37,000
<5000 3
5000–10,000 11
>10,000 20
Practice type
NHS 1
Independent 33
Practice location
Urban 18
Suburban 11
Rural 5
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mild/asymptomatic COPD for annual review as placing unneces-
sary strain on already stretched services. A practice manager, who
described proactively diagnosing cases (of any condition) earlier
as “a luxury”, epitomised this view.
Whether it’s cancer or COPD or dementia or whatever […] it’s
lovely to be able to pick up a case earlier, but you’ve got to
have the resource up-front to be able to invest in picking that
up, and the NHS is so stretched at the moment, that you can’t
afford the luxury of it. Because that’s what it is, really: it’s a
luxury. [Practice Manager 26307, Female]
if people come to you and you give them a diagnosis of mild
COPD, I think you’ve got to question what exactly we’ve got to
offer them. Like I say, is it a case of diagnosing them, they still
smoke and they want to change and take a step to stop
smoking, that’s very good […] but given that we’re only going
to start them on symptomatic management, if they’re not
feeling symptomatic I’m not sure what beneﬁt it is in just
telling them they’ve got mild COPD. [GP 33113, Male]
Potential drawbacks to diagnosing COPD were noted across all
interviews. It was recognised that, for patients, receiving a COPD
diagnosis could entail stress, worry and stigmatisation. People also
commented on the personal ﬁnancial ramiﬁcations of diagnosing
someone with COPD, such as increased insurance costs, adverse
effects on an individual’s occupation, and unnecessary medicalisa-
tion. The ﬁnancial implications for both running case-ﬁnding
initiatives and managing greater numbers of people with COPD
were of particular concern.
Time. […] I’m also looking after all the asthmatics. I’m also
expected to do travel vaccinations, B12s, sorting immunisation,
you name it. It’s a time implication isn’t it? So if I end up with
[100 more] patients with COPD, [who] I’ve got to see a
minimum of 30 min a year, usually more than that, let’s be
honest. So the more patients you have, the more people you’ve
got to see on a regular basis [Practice Nurse 07207, Female]
All interviewees described the challenge of trying to balance
providing best care and meeting clinical need with limited
resources. COPD was contextualised within a larger picture, as one
condition amid many others requiring GP practice attention. There
were two reported priorities at practice level: (1) fulﬁlling local
clinical need and (2) meeting UK clinical targets such as the
‘National Quality and Outcomes Framework (QOF)’ (an incentive
scheme in England offering ﬁnancial rewards to GP practices
meeting speciﬁed clinical targets) and the local targets set by
clinical commissioning groups (CCGs).
Interviewer: So what inﬂuences this prioritisation?
Practice Manager 11301: There are two parts to this, really.
One of them is clinical need, based on the extent of the problem,
and the other one, although it sounds quite bad to say it, is
ﬁnancial. […] for a practice to earn its money, we have to achieve
a certain number of points which are related to the quality and
outcomes framework QOF enhanced service. So we try to balance
it out across all of the areas so that everything is dealt fairly, but
sometimes if you have a low prevalence in one particular area and
it’s higher in the other, it is more—I don’t like using this word, but
it’s more proﬁtable to concentrate on the areas where you have
the higher prevalence […] But as I said, that has to be balanced
with clinical need and the need of the patient.
The mix of nationally (i.e., QOF) and locally (i.e., CCG) deﬁned
targets may explain variance between interviewee accounts as to
how COPD was prioritised at practice level.
I think it’s whatever comes through the door. So if somebody
comes through the door with problems with breathing, it’s a
priority to discover what is causing that, rather than actually
prioritising COPD in itself. [Practice Nurse 14210, Female]
Well, the chronic disease, the QOF has been a big drive, so they
prioritise the clinic highly with the COPD, the diabetes or the
other QOF clinics, as it were, cardiovascular disease. [Practice
Nurse 21211, Female]
Views on approaches to COPD case-ﬁnding
Interviewees were largely supportive of case-ﬁnding as a concept.
Most clinicians and practice managers reported opportunistic
case-ﬁnding to be their practice’s usual approach, although a
small number used both opportunistic and targeted strategies.
Many were interested in the idea of using electronic searches to
undertake targeted case-ﬁnding, viewing this as a potentially
useful approach; some even considered targeted case-ﬁnding to
be the ‘gold standard’, with opportunistic strategies being less
adequate.
you know, I think that—not just for COPD, but I think for
anything, that’s [targeted case-ﬁnding] fantastic, and that’s
obviously the gold standard. [Practice manager 6307, Female]
That’s how I would like to work, where you’re targeting the
people, the actual patients that may well have COPD but
haven’t yet presented for anything to do with COPD. I think it
would be so much better to be able to do that rather than the
opportunistic. [Practice Nurse 29213, Female]
However, some concerns surrounding the practicalities of
targeted case-ﬁnding were highlighted (Table 3). It was noted
that, as clinician recording of patient problems/management in
electronic records could be idiosyncratic, some questioned the
reliability of electronic searches (See 3.1, Table 3). Targeted case-
ﬁnding was associated with increased resource demand com-
pared to opportunistic case-ﬁnding (See 3.2, Table 3). Whilst some
reported interest in engaging in targeted case-ﬁnding irrespective
of how it was resourced, many reported being under considerable
pressure to meet existing practice demands. A key consideration
was how targeted case-ﬁnding would impact on staff time.
I think as long as it was resourced […] I think many people
would be very interested but it would need to be resourced,
either with a research nurse or equivalent funds to do that. I
think trying to recycle it out of current workload would be very
challenging [GP 32112, Male]
Such accounts emphasised the need for targeted case-ﬁnding
to be adequately resourced. Providing externally funded person-
nel to perform the searches or undertake the spirometry was
described as one means of potentially facilitating practice
engagement. The perceived beneﬁts associated with this related
not only to protecting the time of practice staff, but also as a
potential opportunity for educational development. Financially
incentivising case-ﬁnding searches or rewarding practices for
identifying new cases of COPD was another suggestion. Other
practical considerations such as room space and equipment were
also advanced as issues for consideration.
Provided the time and resource, […] and if you can wrap it up
with some education then it’s a win for the practice in terms of
education. […] make sure that the practice sees that both them
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and their patients are getting something positive out of it and
it isn’t going to be too time consuming. [GP 23109, Male]
Another issue related to the potential longer-term ﬁnancial
consequences of identifying more people with COPD (See 3.3,
Table 3). These concerns paralleled those raised in theme 1,
including: (1) increases to the practice’s prescription expenditure,
(2) increased expenditure for secondary care referral, and (3)
decreases to practice income if the practice failed to fulﬁl QOF
criteria for COPD. All of these were described as potential barriers
to engagement with targeted case-ﬁnding.
A key ﬁnding was that not all interviewees thought targeted
case-ﬁnding was worthwhile, with some considering opportunistic
case-ﬁnding to be the best approach. Two GPs and one practice
manager expressed this view, though their explanations differed
slightly. One GP considered the issues with electronic record-
keeping (previously described) to render electronic searching too
unreliable. The other GP argued that opportunistic case-ﬁnding
was more likely to yield a population amenable to behaviour
change, in contrast to targeted case-ﬁnding, which he considered
more likely to identify those who were not ready for advice or
intervention.
I think that this opportunistic case-ﬁnding is deﬁnitely the best
approach to adopt. I don’t think that extending that into
patients who don’t perceive themselves to have a problem is
anywhere near as productive. [GP 08101, Male].
This issue was expressed in other interviews to a lesser degree,
however, those interviewees remained open to targeted case-
ﬁnding, provided searches targeted those who were symptomatic
or with a number of high risk factors.
Interviewees raised several patient-related factors (See 3.4,
Table 3) that they considered would affect the success of targeted
case-ﬁnding, such as low patient turnout rate for screening
appointments, or patients providing incorrect information on
life-style choices (like smoking behaviour and diet). However,
whilst such issues were mentioned by several interviewees, only
one felt that these issues would actually deter their practices from
being involved in a case-ﬁnding study; this was related to the
practice having experienced difﬁculty when attempting targeted
case-ﬁnding previously.
DISCUSSION
Main ﬁndings
There was general support for case-ﬁnding amongst this group of
nurses, GPs and practice managers. Most were very interested in
the idea of targeted case-ﬁnding, but this interest was tempered
by concerns that targeted case-ﬁnding could have limited
effectiveness due to problems with electronic record coding,
and that the additional resources required to implement targeted
case-ﬁnding would have both short-term and long-term ﬁnancial
implications. Within these accounts, there was also concern that
identifying many more people with COPD than there was capacity
to review would lead to a failure to meet ﬁnancial (QOF) targets;
this led some to view targeted case-ﬁnding with caution and some
misgivings. Targeted case-ﬁnding was not viewed favourably by
all interviewees; a small number considered opportunistic case-
ﬁnding to be preferable to targeted case-ﬁnding, as the latter was
perceived as more likely to identify asymptomatic people, or those
with mild COPD (for whom the beneﬁt of early identiﬁcation was
seen as questionable). Lack of patient engagement in screening
programmes was also put forward as a barrier to implementation,
with some interviewees having reservations over participating in
future targeted case-ﬁnding after having experienced low uptake
in previous case-ﬁnding initiatives.
Interpretation of ﬁndings in relation to previously published work
Our ﬁndings echo some of those presented by Haroon et al.,18
reinforcing their likely salience to Primary Care. Like Haroon
et al.,18 we found that clinicians generally supported case-ﬁnding
Table 3. Concerns surrounding targeted case-ﬁnding
Explanation Example quotation
3.1 Staff use different terms/approaches to electronic documentation
(‘read coding’) within and between practices—so reliability of electronic
searches may be poor
Ideally if you were to do case ﬁnding you’d do it with a computer system where
everybody is using the same read codes and using them regularly.
Unfortunately that doesn’t exist in or out of hospital or community care […]
read coding is not a very exact science, everybody that does it does things very
differently in their own practice so it’s very hard to consistently pick up the right
people. We found actually that we were probably just as successful by doing
opportunistic screenings than by actually going through the notes and trawling
for read codes and people who are presenting with certain things. [GP10102,
Male]
3.2 Short term resource implications (stafﬁng, time and space) The cost [of targeted case-ﬁnding]. […] Someone to search the people,
someone to call the people, the nurse then to see them, the healthcare support
worker to do the spirometry, etcetera, etcetera, and as I said, it’s difﬁcult. We’re
ﬁnding it very difﬁcult in our practice at the minute anyway for appointments’
(Nurse Practitioner29216, Female)
3.3 Long term resource implications (maintaining income) “I suppose one of the issues […] is the QOF scenario, where if you suddenly code
all these people as having COPD, QOF would like them to have an annual
review. They’d like them to have the regular spirometry, […] particularly in a
small practice like myself, […] even if the initial work had been done in the
case-ﬁndings, the diagnoses and the education and things, it might be difﬁcult.
[…] and that’s [QOF generate] the sort of money that pays for the nurses, the
annual health checks and things.”[GP33113, Male]
3.4 Patient candour and uptake of case-ﬁnding invitations “trying to also persuade people to come in for screening can be difﬁcult. […] I
get this list and I ring these patients up to try and persuade them to come in,
and they make excuses. There are some that are very happy to come in, but
there are some that are quite resistant, and I think they worry that you’re going
to tell them off because they’re smokers” [Practice Nurse06206, Female]
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and that opportunistic case-ﬁnding was the most common
description of usual practice. However, while many of our
interviewees felt early diagnosis was desirable, others questioned
the beneﬁt of diagnosing mild COPD. Arguments against
diagnosing mild COPD were that: (1) this group (who were
considered unlikely to be experiencing noticeable deﬁcits) would
be less amenable to changing behaviour, such as smoking; (2)
intervention for mild COPD would not make a substantial
difference; (3) the cost associated with the increased number of
review appointments needed, and additional interventions or
referrals, would outweigh the beneﬁts of early diagnosis. Whilst
such views were not reported in Haroon et al.18 study, Walters
et al.14 previously identiﬁed ‘nihilistic’ attitudes to diagnosing
COPD amongst GPs in primary care. Yet, unlike Walters et al.14
research, clinicians in this sample were not against diagnosing
COPD in general, only in mild or asymptomatic cases where the
impact of the condition was not thought considerable enough to
motivate behaviour change or have a signiﬁcant impact on
outcomes. The debate around whether early diagnosis is
beneﬁcial is not new. In 1999, White16 published a commentary
arguing against Thomas and Levy15 published work, which had
recommended increasing early diagnosis of COPD. Today, there is
discourse supporting early diagnosis,4, 19, 20 but our study reﬂects
the ongoing potential for uncertainty amongst clinicians about
the value of early diagnosis of COPD. Clinicians who remain
unconvinced will require evidence of beneﬁt for early diagnosis,
underscoring the need for further research assessing the impact of
diagnosing mild COPD, and the impact of early intervention.
There was a frequently expressed need for additional resources
and support to enable practices to engage in targeted case-
ﬁnding initiatives and to cater for those patients identiﬁed as a
result, as reported by Haroon et al.18 This is perhaps unsurprising
given the considerable increase in demand for primary care
appointments21 and the general stafﬁng and resource challenges
currently facing GP practices.22, 23 Like Haroon et al.18 participants,
our interviewees were concerned that their already over-
burdened practices would not have capacity to meet the needs
of a patient population expanding due to an increase in
diagnosed COPD; with capacity to perform yearly reviews being
of particular concern.
Another ﬁnding was concern about the potential for incurring
ﬁnancial losses as a result of failing to meet QOF targets, which
could act as a deterrent to GP practice engagement. Conversely,
some interviewees welcomed identifying more people with COPD
within their practices, believing this to be beneﬁcial for both
improving patient care and generating QOF related revenue for
the practice. To our knowledge, the importance of QOF, whilst
evident in this study, has not been explicitly identiﬁed in earlier
work into case-ﬁnding for COPD,18 though previous literature has
raised the issue of QOF shaping GP practice behaviours in other
areas.24–26
Strengths and limitations of this study
This study was implemented following a careful, methodologically
robust design. Multiple coding and peer review from our
multidisciplinary research team was used to critically analyse the
data collected. Whilst we were unable to obtain a purposive
sample, the sample contained GP practice staff from practices of
varying demographics (list sizes, urban vs. rural) from regions in
the south of the UK (Wiltshire, Dorset, Hampshire) and was not
associated with an ongoing case-ﬁnding study. Our participants,
who were diverse in relation to age, sex, years of primary care
experience and special interest in COPD, provided insights into
case-ﬁnding for COPD; for this reason, we do not believe that
recruitment limitations unduly affected our ﬁndings.
Implications for future research, policy and practice
Further research investigating the cost-beneﬁt of identifying and
managing mild/asymptomatic COPD is needed. Strategies to
support practices to meet their population demands and any
additional resource or ﬁscal implications of identifying more
people with COPD are needed. As such, research to identify
clinically and cost effective case-ﬁnding approaches is needed.
This will need to include long term follow-up to fully understand
the impact of case-ﬁnding in relation to disease progression,
clinical outcomes and socioeconomic cost. This study has high-
lighted professionals’ concerns over patient engagement in
screening programmes; further research is therefore needed to
understand patient uptake of case-ﬁnding appointments to
identify (1) to what extent patients in primary care engage in
case-ﬁnding and (2) what factors facilitate or inhibit such
engagement.
CONCLUSIONS
While primary care HCPs in this study generally supported case-
ﬁnding and the need to diagnose COPD, views were mixed
regarding the value of targeted case-ﬁnding and identifying those
with mild/asymptomatic COPD. Key concerns were lack of
evidence for the effectiveness or beneﬁt of targeted case-
ﬁnding vs. perceived potential disadvantages to patients, and
concerns over ﬁnancial implications and need for additional
resources. The successful implementation of targeted case-ﬁnding
for COPD in primary care faces a number of barriers. Our ﬁndings
suggest that one way to enhance practice engagement with
targeted case-ﬁnding initiatives or studies would be to provide
additional administrators and clinicians to support targeted
searches, and to perform the spirometry tests needed to diagnose
COPD.
METHODS
A qualitative semi-structured interview design was used to capture
participant views. The study was designed and implemented using a
subtle realist, pragmatic approach. By taking a subtle realist position, we
tried to capture a truthful account of the research topic, while recognising
that only a best approximation of truth may ever be obtained.27 A
pragmatic approach meant we selected data collection and analysis
strategies appropriate to the research aim, without reference to a particular
theoretical lens.28
Ethical approval for this study was granted by the University of
Southampton Research Ethics Committee (Ethics no. 12647) and methods
were performed in accordance with relevant regulations/guidelines. GPs,
practice managers, and practice nurses involved in the management of
COPD (or in the triage of patients with acute exacerbations of COPD),
working in a primary care practice at the time of the study, were eligible to
participate.
We aimed to obtain a diverse sample including staff from urban,
suburban and rural practices with a range of patient list sizes, with varying
years’ experience in primary care and/or managing COPD. We sought GPs
who were respiratory leads and those who were not, salaried GPs and GP
partners. Interviews were planned to continue until data saturation had
occurred, where subsequent interviews ceased to provide new informa-
tion,28 or up to 45 participants (n = 15 from each group) had been
recruited.
As a diverse sample was sought, the study was advertised as widely as
possible. Study recruitment packs (study invitation, information sheet and
brief demographics form) were sent via email to the practice manager of
99 GP practices in Wessex; practice managers were asked to disseminate
the study invitation amongst all GP and nursing staff. The study was also
advertised at a North Hampshire Primary Care Meeting (n = 10 practices in
attendance), via social media and the Respiratory Primary Care Education
Database. Those interested in participating returned their demographics
form by email or hard copy and were contacted by the research team to
discuss the study in more detail and to establish eligibility. Snowballing
was used to supplement recruitment where it would add diversity to the
demographic proﬁle of the sample, or the perspectives already captured
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within. Written consent was obtained from all participants prior to a
telephone interview. A £50 incentive was offered to participants to cover
time and inconvenience.
Data collection
Participants took part in a telephone interview, conducted by TS, a
Research Fellow with experience of utilising qualitative in methods. Prior to
study commencement, participants were previously unknown to TS and no
information about the researcher was provided to participants. Interviews
were audio-recorded digitally, and followed a staff speciﬁc interview guide
(Table 4) which was informed by relevant literature,14, 18 developed by RS,
KL, KG, CA, MSW, AB, MT and TW, and reﬁned following peer review by two
independent Research Fellows with expertise in qualitative methods.
Interviews ranged from 24 to 79min (median 41:22 min). Audio-recordings
were transcribed verbatim by a professional transcriber and checked by TS
for accuracy. Initial interview transcripts from each staff group were
circulated among RS, KL, KG, CA, and TW, who provided peer review and
advice, prior to further interviews.
Data analysis
Data were managed using NVivo 10 software and analysed using
Framework Approach,29 which consisted of ﬁve analytic steps:
(1) Familiarisation: the ﬁrst ﬁve GP, nurse and practice manager
transcripts collected were repeatedly read to identify recurrent
concepts and ideas.
(2) Preliminary thematic framework development: recurrent concepts
identiﬁed during the familiarisation process are grouped into initial
themes.
(3) Indexing: the preliminary thematic framework was then applied
consistently to all the transcripts. As indexing continued, the
preliminary framework was reﬁned to ensure the framework
adequately captured views expressed within the interviews.
(4) Charting: each segment of raw data indexed within the framework
was summarised.
(5) Mapping: That the range of opinions across the data, and the
similarities and differences within the data, were described.
TS acted as primary analyst, analysing all data. Other authors (RS, KL, KG,
CA, LV, MSW, AB, MT, TW) provided multiple coding and peer review at
points throughout the analysis to enhance rigour, with RS, a Senior
Research Fellow with doctoral and post-doctoral experience of qualitative
methods, supervising and coordinating analysis. Team meetings to discuss
the data analysis were held regularly; where coder/peer reviewer
interpretation of the data differed from the primary analyst, differences
were discussed and resolved by team consensus. Participant checking was
not used.
Data availability
All data and internal working documents generated and used during this
study are held at the University of Southampton and are available from the
corresponding author upon reasonable individual access to document
request according to University of Southampton policy and NHS Research
Ethics Committee approval.
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Table 4. Interview guide questions
The following outlines the main interview questions. Please note, for brevity, only the chief interview question is included below, prompts have been
removed.
Staff speciﬁc interview guide questions
Questions for nurses
•What do you think the role of the nurse is in the management of COPD?
•Have you suggested to a GP that a diagnosis of COPD might be appropriate for a particular patient or assisted in making a diagnosis of COPD? If yes,
what lead you to believe they had COPD?
Questions for GPs
•What do you think the role of the GP is in the management of COPD?
•What would make you suspect a patient has COPD?
Questions for Practice Managers
•What do you think the role of the practice manager is in primary care?
Questions for all staff groups
• In relation to diagnosing COPD, how well do you think the UK is doing?
• Some ﬁgures suggest 2 million more people in the UK may have COPD than are currently diagnosed. How important is it to identify people with
COPD?
•What do you think about the idea of case-ﬁnding as a way of identifying people with COPD?
• If we were to run case-ﬁnding in GP practices in the future, how interested do you think practices would be to participate?
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